Pyrazine, 2-ethoxymethyl-
| Common Name: |
Pyrazine, 2-ethoxymethyl- |
| IUPAC Name: |
2-(ethoxymethyl)pyrazine |
| Molecular Formula: |
C7H10N2O |
| SMILES: |
CCOCC1=NC=CN=C1 |
| Inchi: |
1S/C7H10N2O/c1-2-10-6-7-5-8-3-4-9-7/h3-5H,2,6H2,1H3 |
| Inchi Key: |
HAKYWHMNHHQQJR-UHFFFAOYSA-N |
| Cas No: |
65504-94-1 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
2 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
138.17 |
| Mass (g/mol) |
138.079 |
| Molar Refractivity |
37.70 |
| Net Charge |
|
| HBD |
|
| HBA |
3 |
| Rt Bonds |
3 |
| Rings |
1 |
| TPSA |
35.01 |
| Hetero Atoms |
3 |
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
175.00 to 176.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.746 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.43 |
| LogP |
1.013 |
| iLOGP |
1.57 |
| XLOGP3 |
-0.16 |
| WLOGP |
0.86 |
| MLOGP |
-0.66 |
| ESOL Log S |
-0.84 |
| ESOL Solubility (mg/ml) |
19.9 |
| ESOL Solubility (mol/l) |
0.144 |
| ESOL Class: esol_class |
Very soluble |
| Ali Log S |
-0.12 |
| Ali Solubility (mg/ml) |
105 |
| Ali Solubility (mol/l) |
0.76 |
| Ali Class |
Very soluble |
| Silicos-IT LogSw |
-2.56 |
| Silicos-IT Solubility (mg/ml) |
0.38 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-7.26 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.28 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
2.075 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
